Beijing Kejing Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Beijing Kejing Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients (NCT06284226) | Beijing Kejing Biotechnology Co., Ltd. | 2022-03-25 |
Track Beijing Kejing Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.